Drug boosts snakebite survival time by half: study

June 26, 2011

Rubbing snakebites with an ointment that slows the functioning of lymph glands could boost survival times by 50 percent, according to a study released Sunday.

In experiments on humans and mice, researchers in Australia showed that a class of compounds called nitric oxide donors delays the entry of toxins from potentially deadly snakebites into the blood stream.

Nitric oxide (NO), a molecule involved in regulation of blood pressure and the control of , has been shown to in patients who suffer acute strokes.

The new finding is of more than academic interest: every year some 100,000 people worldwide die from snakebites, and another 400,000 must amputate limbs that have been injected with poison.

It has long been known that many snake venoms contain large molecules that transit the human body's before entering the .

Separately, scientists have also established that nitric oxide slows down a pumping mechanism within the lymphatic system, a part of the body's immune system that carries a clear fluid -- called lymph -- toward the heart.

Dirk van Helden, a researcher at the University of Newcastle in New South Wales, put these two facts together to suggest a possible treatment for snakebites.

"We hypothesised that a nitric oxide-releasing agent applied topically would slow lymphatic transit time and entry of the into the circulation, delaying onset of toxicity," he and his colleagues wrote in the study.

To test their theory, the researchers injected a venom-like substance into one foot of 15 volunteers, and measured the time it took for the substitute to reach lymph nodes in the groin.

The experiment was later repeated, except this time the drug-laced ointment was spread around the puncture within one minute of the injection.

Result: the transit time dropped from an average of 13 minutes to 54 minutes, four times slower.

Further experiments using real toxins in rats yielded roughly the same results.

Finally, the researchers compared the survival time in rats injected with venom that were treated with the ointment against those that were not, and found that the rats kept breathing 50 percent longer.

"These results point to a new method of snakebite first aid that may also be useful for bites to the torso or head," the researchers concluded.

Currently, the most common treatment is to immobilise the patient and restrict blood flow as much as possible until medical assistance is available.

Explore further: Nitric oxide: Experimental analysis of its role in brain tissue in simulated ischemia

More information: A pharmacological approach to first aid treatment for snakebite, Nature Medicine (2011) doi:10.1038/nm.2382 . www.nature.com/nm/journal/vaop … nt/full/nm.2382.html

Abstract
Snake venom toxins first transit the lymphatic system before entering the bloodstream. Ointment containing a nitric oxide donor, which impedes the intrinsic lymphatic pump, prolonged lymph transit time in rats and humans and also increased rat survival time after injection of venom. This pharmacological approach should give snakebite victims more time to obtain medical care and antivenom treatment.

Related Stories

Nitric oxide: Experimental analysis of its role in brain tissue in simulated ischemia

November 10, 2017
A joint study conducted by scientists at the National Academy of Sciences in Belarus and Kazan Federal University in Russia, looks at the role of nitric oxide (NO) in brain tissue in simulated ischemia in rats.

How genes and environment interact to raise risk of congenital heart defects

October 19, 2017
Infants of mothers with diabetes have a three- to five-fold increased risk of congenital heart defects. Such developmental defects are likely caused by a combination of genetic and environmental factors. However, the molecular ...

New wake-promoting node pinpointed in brain

November 10, 2017
Scientists have identified an additional group of cells in the brain responsible for keeping us awake: the supramammillary nucleus, part of the caudal hypothalamus.

Research identifies potential targets for treatment of leishmaniasis

October 6, 2017
Brazilian researchers at the University of São Paulo's Bioscience Institute (IB-USP) are starting to unravel the molecular mechanisms by which the parasite that causes cutaneous leishmaniasis circumvents the host organism's ...

Leprosy turns the immune system against itself, study finds

August 24, 2017
Leprosy hijacks our immune system, turning an important repair mechanism into one that causes potentially irreparable damage to our nerve cells, according to new research that uses zebrafish to study the disease. As such, ...

Basis established for nitric oxide joining oxygen and carbon dioxide in respiratory cycle

April 10, 2015
Professor Jonathan Stamler's latest findings regarding nitric oxide have the potential to reshape fundamentally the way we think about the respiratory system - and offer new avenues to save lives. It may be time to rewrite ...

Recommended for you

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

New painkillers reduce overdose risk

November 16, 2017
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing—the cause of opiate overdose.

Separating side effects could hold key for safer opioids

November 16, 2017
Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops. Scientists have discovered a way to separate these ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

Introduction is different, but top medications for opioid addiction equally effective

November 14, 2017
With opioid addiction officially declared a public health emergency in the U.S., medical intervention to treat the illness is increasingly important in responding to the epidemic. Now, a new study concludes that two of the ...

Drugstore pain pills as effective as opioids in ER patients

November 7, 2017
Emergency rooms are where many patients are first introduced to powerful opioid painkillers, but what if doctors offered over-the-counter pills instead? A new study tested that approach on patients with broken bones and sprains ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Telekinetic
1 / 5 (2) Jun 26, 2011
How great that I won't have to suck the poison and spit it out anymore.
Argon
not rated yet Jun 27, 2011
The title is a bit confusing, other than that very nice article!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.